AQIX RS-I
Pre-clinical- Indications
- Cardiopulmonary bypass surgery
Company intelligence / Profile preview
Aqix Limited
Canterbury / Barham, England, United Kingdomzoominfo.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Preclinical
01
Overview
Aqix Limited develops and commercializes synthetic interstitial fluids that replicate the conditions of the human body to keep tissues alive ex vivo. Their lead product, Aqix RS-I, is widely used by pharmaceutical companies for human tissue research. The company is also developing this technology for potential transplant and blood expansion uses.[2] No clinical trial results as their main products are not therapeutics.
- Therapeutic areas
- Other
- Modalities
- Synthetic interstitial fluid
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Aqix Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aqix Limited.